Literature DB >> 8421277

Purine 2'-deoxy-2'-fluororibosides as antiinfluenza virus agents.

J V Tuttle1, M Tisdale, T A Krenitsky.   

Abstract

Twenty purine 2'-deoxy-2'-fluororibosides were synthesized by enzymic pentosyl transfer from 2'-deoxy-2'-fluorouridine. Each nucleoside analogue was assayed for cytotoxicity in uninfected Madin-Darby canine kidney cells and for their ability to suppress influenza A virus infections in these cells. The most potent antivirial activity was observed with analogues having an amino group in the 2-position of the purine moiety. All 2-unsubstituted analogues were less potent than their 2-amino counterparts. Furthermore, 2-methyl,2-methoxy, or 2-fluoro substitution obliterated antivirial activity. The most cytotoxic member of the series was the 2-fluoro-6-amino analogue (IC50 = 120 microM). 2'-Deoxy-2'-fluoroguanosine and those congeners readily converted to it by adenosine deaminase showed the most potent antivirial activity (IC50 = 15-23 microM). Little cytotoxicity was observed with this subgroup of analogues which renders them worthy of further investigation as potential antiinfluenza agents.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8421277     DOI: 10.1021/jm00053a015

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  Antiviral screening identifies adenosine analogs targeting the endogenous dsRNA Leishmania RNA virus 1 (LRV1) pathogenicity factor.

Authors:  F Matthew Kuhlmann; John I Robinson; Gregory R Bluemling; Catherine Ronet; Nicolas Fasel; Stephen M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

2.  In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections.

Authors:  Yohichi Kumaki; Craig W Day; Donald F Smee; John D Morrey; Dale L Barnard
Journal:  Antiviral Res       Date:  2011-09-08       Impact factor: 5.970

3.  Inhibition of influenza virus transcription by 2'-deoxy-2'-fluoroguanosine.

Authors:  M Tisdale; M Ellis; K Klumpp; S Court; M Ford
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

4.  Oral administration of cyclopentane neuraminidase inhibitors protects ferrets against influenza virus infection.

Authors:  Clive Sweet; Kenneth J Jakeman; Karen Bush; Pamela C Wagaman; Linda A McKown; Anthony J Streeter; Daksha Desai-Krieger; Pooran Chand; Yarlagadda S Babu
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

5.  Silver ions blocking crystallization of guanosine-based hydrogel for potential antimicrobial applications.

Authors:  Hui Feng; Yuqi Du; Fan Tang; Ning Ji; Xuefeng Zhao; Hang Zhao; Qianming Chen
Journal:  RSC Adv       Date:  2018-04-27       Impact factor: 4.036

6.  New trends in nucleoside biotechnology.

Authors:  I A Mikhailopulo; A I Miroshnikov
Journal:  Acta Naturae       Date:  2010-07       Impact factor: 1.845

Review 7.  Nucleosides for the treatment of respiratory RNA virus infections.

Authors:  Paul C Jordan; Sarah K Stevens; Jerome Deval
Journal:  Antivir Chem Chemother       Date:  2018 Jan-Dec

Review 8.  Anti-influenza virus agents: synthesis and mode of action.

Authors:  Irene M Lagoja; Erik De Clercq
Journal:  Med Res Rev       Date:  2008-01       Impact factor: 12.944

Review 9.  Antiviral agents active against influenza A viruses.

Authors:  Erik De Clercq
Journal:  Nat Rev Drug Discov       Date:  2006-12       Impact factor: 84.694

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.